Vaccination in women

Recommendations across the life cycle

Abstract

Vaccination in women constitutes an essential strategy for the prevention of infectious diseases with major public health impact and for the reduction of avoidable morbidity and mortality. Throughout the female life cycle, specific vaccines are recommended, including human papillomavirus (HPV), influenza, hepatitis A and B, tetanus-diphtheria-acellular pertussis (Tdap), measles-mumps-rubella (MMR), varicella, COVID-19, pneumococcus, respiratory syncytial virus (RSV), herpes zoster, and yellow fever. The indication for each vaccine depends on factors such as age, pregnancy, the presence of comorbidities, or immunosuppression status. Individualization of vaccination schedules, with emphasis on pregnant women, immunocompromised patients, and women over 50 years of age, is key to optimizing protection. Timely updates of immunization schemes represent a cost-effective measure to strengthen women’s overall health